UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 15, 2024
Accession Number:
0001193125-24-036591
Submission Type:
POS AM
CIK:
0001445499
Company Name:
IMPEL PHARMACEUTICALS INC
File Number:
333-264987